HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Renal osteodystrophy in two children : a comparison of the effects of 1 alpha-hydroxycholecalciferol (author's transl)].

Abstract
Two children suffering from renal osteodystrophy were treated by 1 alpha hydroxycholecalciferol (1 alpha OHD3) 1 microgr. each day, for 18 months. In both the level alkaline phosphatase decreased at the same time as endogenous immunoreactive CT increased, iPTH did not change steadily, whereas plasma creatinine rise. As plasma calcium concentration did not increase, it is suggested that the increase in endogenous CT concentration is a part of the favourable response to the treatment by 1 alpha OHD3.
AuthorsJ M Chantraine, J C Davin, L Lambrechts, G Heynen
JournalAnnales d'endocrinologie (Ann Endocrinol (Paris)) Vol. 40 Issue 2 Pg. 161-2 ( 1979) ISSN: 0003-4266 [Print] France
Vernacular TitleComparaison de deux cas d'ostéodystrophie rénale sévère chez l'enfant, traités par la 1 alpha hydroxycholecalciferol (1 alpha OHD).
PMID475307 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Hydroxycholecalciferols
  • Parathyroid Hormone
  • Calcitonin
  • Creatinine
  • Alkaline Phosphatase
Topics
  • Alkaline Phosphatase (blood)
  • Calcitonin (blood)
  • Child
  • Chronic Kidney Disease-Mineral and Bone Disorder (blood, drug therapy)
  • Creatinine (blood)
  • Humans
  • Hydroxycholecalciferols (therapeutic use)
  • Parathyroid Hormone (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: